These activities are approved for AMA PRA Category 1 Credits.™
This activity is intended for ophthalmologists with an interest in the anterior segment.
Ophthalmologists attending this meeting will:
- Implement best practices in the diagnosis, preparation for, and surgical management of complex cataract cases.
- Describe and integrate key elements to improve cataract refractive outcomes to meet increased patient expectations, including evaluating and integrating advanced technology IOLs and laser-assisted cataract surgery
- Compare advances in therapeutics and surgical management options for the treatment of glaucoma
- Improve practice protocols for the screening, diagnosis, and classification of ocular surface and dry eye disease, evaluate the effects of various therapeutic classes and treatments, and integrate consistent treatment regimens.
- Analyze the efficacy of emerging technologies in corneal refractive surgery
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld news magazine.
ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.
The American Society of Cataract and Refractive Surgery designates this live educational activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation
in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice.
ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations or services should contact Shelly Dixon at email@example.com by January 23, 2017.